Compounds > 3,4,3',4'-tetrachloroazoxybenzene
Page last updated: 2024-12-06
3,4,3',4'-tetrachloroazoxybenzene
Description
3,4,3',4'-Tetrachloroazoxybenzene, also known as TCAB, is a persistent organic pollutant (POP) that has been widely used as a fungicide and insecticide. It is synthesized through the reaction of 3,4-dichloroaniline with sodium nitrite in acidic conditions. TCAB is highly toxic to various organisms and has been found to bioaccumulate in food chains. Its persistence in the environment, its potential for bioaccumulation, and its toxicity have led to concerns about its impacts on human health and ecosystems. Research on TCAB focuses on its environmental fate and transport, its toxicological effects, and its remediation strategies. Studies have investigated its degradation pathways in different environmental compartments, its bioaccumulation in organisms, and its potential for causing endocrine disruption, cancer, and other adverse health effects. Further research is needed to better understand the long-term consequences of TCAB exposure and to develop effective strategies for its control and remediation.'
```
3,4,3',4'-tetrachloroazoxybenzene: unwanted contaminant found in commercial synthesis of dichloroaniline or herbicides made from dichloroaniline; implicated in outbreak of acne in chemical workers [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 30533 |
MeSH ID | M0060910 |
Synonyms (12)
Synonym |
tcaob |
bis(3,4-dichlorophenyl)diazene 1-oxide |
azoxybenzene, 3,3',4,4'-tetrachloro- |
diazene, bis(3,4-dichlorophenyl)-, 1-oxide |
3,4,3',4'-tetrachloroazoxybenzene |
ccris 3013 |
1,2-dichloro-4-(3,4-dichlorophenyl)-nno-azoxybenzene |
3,3',4,4'-tetrachloroazoxybenzene |
21232-47-3 |
(3,4-dichlorophenyl)-(3,4-dichlorophenyl)imino-oxidoazanium |
DTXSID1026087 |
3,3',4,4'-tetrachloroazoxybenzene 100 microg/ml in acetonitrile |
Research Excerpts
Toxicity
Excerpt | Reference | Relevance |
" Both TCAB and TCAOB were more toxic than all other chemicals that have been tested in the chick embryo with the exception of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)." | ( Embryotoxicity of 3,3',4,4'-tetrachloroazobenzene and 3,3',4,4'-tetrachloroazoxybenzene in the chick embryo. Hsia, MT; Kreamer, BL; Schrankel, KR, 1982) | 0.26 |
Bioavailability
Excerpt | Reference | Relevance |
" Absolute bioavailability was calculated to be approximately 9%." | ( Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat. Kattnig, MJ; Liebler, DC; Mayersohn, M; Pillai, UA; Sipes, IG; Smith, RL; Ziegler, TL, 1996) | 0.29 |
Dosage Studied
Excerpt | Relevance | Reference |
" In 2 groups of weanling rats the same dosage of TCAOB was able to reduce the relative thymus weight to 31% and 38% of the comparable control animals." | ( Thymic atrophy induced by acute exposure of 3,3',4,4'-tetrachloroazobenzene and 3,3',4,4'-tetrachloroazoxybenzene in rats. Burant, CF; Hsia, MT; Kreamer, BL; Schrankel, KR, 1982) | 0.26 |
Research
Studies (22)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 17 (77.27) | 18.7374 |
1990's | 4 (18.18) | 18.2507 |
2000's | 1 (4.55) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.14
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.14 (24.57) | Research Supply Index | 3.18 (2.92) | Research Growth Index | 4.31 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 23 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |